Sharef Al-Mulaabed
Overview
Explore the profile of Sharef Al-Mulaabed including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
5
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ajmera A, Thio J, Al-Mulaabed S, Bornstein J
JPGN Rep
. 2025 Feb;
6(1):71-73.
PMID: 39944102
No abstract available.
2.
Alkaabi S, Alzidjali A, Pathare A, Alghaithi I, Alkhabori M, Elshinawy M, et al.
Haemophilia
. 2024 May;
30(4):1080-1083.
PMID: 38738970
No abstract available.
3.
Sakr M, Al Kanjo M, Balasundaram P, Kupferman F, Al-Mulaabed S, Scott S, et al.
Pediatr Qual Saf
. 2024 Apr;
9(2):e721.
PMID: 38576889
Background: Current national guidelines recommend against chest X-rays (CXRs) for patients with acute asthma exacerbation (AAE). The overuse of CXRs in AAE has become a concern, prompting the need for...
4.
Khater D, Al-Mulaabed S, Alomairi A, Elshinawy M, Soliman A, Elshinawy N, et al.
Hemoglobin
. 2023 Sep;
47(4):157-162.
PMID: 37691435
Growth impairment is a known complication of sickle cell disease (SCD). Few studies explored the potential effects of hydroxyurea (HU) on growth in children with SCD in relation to HU...
5.
Singh N, Will L, Al-Mulaabed S, Ruoss L, Li N, de la Cruz D, et al.
Am J Perinatol
. 2023 Jun;
41(S 01):e2248-e2253.
PMID: 37308133
Objective: Antibiotics are one of the most widely used medications in today's neonatal intensive care units. Indiscriminate antibiotic usage persists in preterm newborns who are symptomatic due to factors linked...
6.
Al Sinani S, Al-Mulaabed S, Al Naamani K, Sultan R
Oman Med J
. 2019 Nov;
34(6):482-489.
PMID: 31745411
Cystic fibrosis (CF) is a multisystem disease caused by mutations in the CF transmembrane conductance regulator (CFTR) gene. CFTR is expressed in the apical surface of cholangiocytes. Homozygous CFTR gene...